A Comparison between Levofloxacin and Cefuroxime with Azithromycin in Community-acquired Pneumonia
Song Jian-mi
Abstract
Song Jian-mi
Abstract
Objective To compare the clinical effects,bacterium clearances and safety of levofloxacin and cefuroxime with azithromycin in treatment of community-acquired pneumonia(CAP).Methods Seventy-five CAP patients were randomly divided into groups levofloxacin(therapy group,n=40) and cefuroxime plus azithromycin(control group,n=35),to observe the efficacy,pathogen clearance rates and side effects.Results In therapy group,33 were clinical cured(82.5%),4 improved(10.0%),and the total effective rate,bacterium clearance and adverse reaction incidence were 92.5%,94.7%,2.5%,respectively.In control group,28 cured(80.0%),4 improved(11.4%),and the total effective rate,bacterium clearance and adverse reaction incidence were 91.4%,92.3%,2.9%,respectively,there were no significant differences between two groups(P0.05).Conclusion Medication of treatment group is given once/d,in a large dose,and the patients′ compliance is better than that of control (twice/d),with good tolerability and low incidence of adverse reactions.This medication will further expand the application of levofloxacin in CAP treatment.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To compare the clinical effects,bacterium clearances and safety of levofloxacin and cefuroxime with azithromycin in treatment of community-acquired pneumonia(CAP).Methods Seventy-five CAP patients were randomly divided into groups levofloxacin(therapy group,n=40) and cefuroxime plus azithromycin(control group,n=35),to observe the efficacy,pathogen clearance rates and side effects.Results In therapy group,33 were clinical cured(82.5%),4 improved(10.0%),and the total effective rate,bacterium clearance and adverse reaction incidence were 92.5%,94.7%,2.5%,respectively.In control group,28 cured(80.0%),4 improved(11.4%),and the total effective rate,bacterium clearance and adverse reaction incidence were 91.4%,92.3%,2.9%,respectively,there were no significant differences between two groups(P0.05).Conclusion Medication of treatment group is given once/d,in a large dose,and the patients′ compliance is better than that of control (twice/d),with good tolerability and low incidence of adverse reactions.This medication will further expand the application of levofloxacin in CAP treatment.
Key concepts: Medicine, Cefuroxime, Levofloxacin, Azithromycin, Community-acquired pneumonia, Tolerability, Pneumonia, Adverse effect